Targeting an epigenetic pathway to treat asthma

靶向表观遗传途径治疗哮喘

• 批准号: nhmrc : 1100451
• 负责人: A/Pr Christopher Burns
• 金额: $ 30.42万
• 依托单位: The Walter and Eliza Hall Institute of Medical Research
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/targeting-an-epigenetic-treat-asthma/662513
• 关键词: Targeting; epigenetic; pathway; treat; asthma

This project proposes to identify novel components and develop new inhibitors of an epigenetic pathway known to control the immune cells that cause allergic asthma. Our objective is to use these drugs to treat allergic disease.

该项目提出鉴定新的成分和开发新的表观遗传途径的抑制剂，以控制引起过敏性哮喘的免疫细胞。我们的目标是用这些药物治疗过敏性疾病。